Eugene P Orringer

UNCCH, School of Medicine, Medicine

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network

Eugene P Orringer

• Organizations
  University of North Carolina at Chapel Hill
  
  School of Medicine
  
  Medicine
  
  

Help us refine your profile

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2012

  Mark Hollins; Gregory L. Stonerock; Nkaku R. Kisaalita; Susan Jones; Eugene Orringer; Karen M. Gil

  Detecting the emergence of chronic pain in sickle cell disease

  Journal of Pain and Symptom Management. 2012;43(6):1082-1093.
  0

• 2.

  2011

  Allison E. Ashley-Koch; Emmanuel C. Okocha; Melanie E. Garrett; Karen Soldano; Laura M. de Castro; Jude C. Jonassaint; Eugene P. Orringer; James R. Eckman; Marilyn J. Telen

  MYH9 and APOL1 are both associated with sickle cell disease nephropathy

  British Journal of Haematology. 2011;155(3):386-394.
  6

• 3.

  2011

  Kenneth I. Ataga; Julia E. Brittain; Susan K. Jones; Ryan May; John Delaney; Dell Strayhorn; Payal Desai; Rupa Redding-Lallinger; Nigel S. Key; Eugene P. Orringer

  Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease

  British Journal of Haematology. 2011;152(4):485-491.
  3

• 4.

  2010

  Kenneth I. Ataga; Julia E. Brittain; Dominic Moore; Susan K. Jones; Ben Hulkower; Dell Strayhorn; Soheir Adam; Rupa Redding-Lallinger; Patrick Nachman; Eugene P. Orringer

  Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: Potential role of soluble fms-like tyrosine kinase-1

  European Journal of Haematology. 2010;85(3):257-263.
  7

• 5.

  2010

  Martin H. Steinberg; William F. McCarthy; Oswaldo Castro; Samir K. Ballas; F. Danny Armstrong; Wally Smith; Kenneth Ataga; Paul Swerdlow; Abdullah Kutlar; Laura DeCastro; et al.

  The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up

  American Journal of Hematology. 2010;85(6):403-408.
  50

• 6.

  2010

  Elliott P. Vichinsky; Lynne D. Neumayr; Jeffrey I. Gold; Michael W. Weiner; Randall R. Rule; Diana Truran; Jeffrey Kasten; Barry Eggleston; Karen Kesler; Lillian McMahon; et al.

  Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia

  JAMA - Journal of the American Medical Association. 2010;303(18):1823-1831.
  27

• 7.

  2010

  Julia E. Brittain; Ben Hulkower; Susan K. Jones; Dell Strayhorn; Laura De Castro; Marilyn J. Telen; Eugene P. Orringer; Alan Hinderliter; Kenneth I. Ataga

  Placenta growth factor in sickle cell disease: Association with hemolysis and inflammation

  Blood. 2010;115(10):2014-2020.
  6

• 8.

  2008

  Soheir Adam; Jude Jonassaint; Hillary Kruger; Melanie Kail; Eugene P. Orringer; James R. Eckman; Allison Ashley-Koch; Marilyn J. Telen; Laura M. De Castro

  Surgical and Obstetric Outcomes in Adults with Sickle Cell Disease

  American Journal of Medicine. 2008;121(10):916-921.
  7

• 9.

  2008

  Allison E. Ashley-Koch; Laine Elliott; Melanie E. Kail; Laura M. De Castro; Jude Jonassaint; Terry L. Jackson; Jennifer Price; Kenneth I. Ataga; Marc C. Levesque; J. Brice Weinberg; et al.

  Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease

  Blood. 2008;111(12):5721-5726.
  19

• 10.

  2008

  Julia E. Brittain; Christine M. Knoll; Kenneth I. Ataga; Eugene P. Orringer; Leslie V. Parise

  Fibronectin bridges monocytes and reticulocytes via integrin α4β1

  British Journal of Haematology. 2008;141(6):872-881.
  10

• 11.

  2008

  Araba Afenyi-Annan; Melanie Kail; Martha R. Combs; Eugene P. Orringer; Allison Ashley-Koch; Marilyn J. Telen

  Lack of Duffy antigen expression is associated with organ damage in patients with sickle cell disease

  Transfusion. 2008;48(5):917-924.
  17

• 12.

  2008

  Kenneth I. Ataga; Wally R. Smith; Laura M. De Castro; Paul Swerdlow; Yogen Saunthararajah; Oswaldo Castro; Elliot Vichinsky; Abdullah Kutlar; Eugene P. Orringer; Greg C. Rigdon; et al.

  Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia

  Blood. 2008;111(8):3991-3997.
  47

• 13.

  2008

  Kenneth I. Ataga; Charity G. Moore; Cheryl A. Hillery; Susan Jones; Herbert C. Whinna; Dell Strayhorn; Cathy Sohier; Alan Hinderliter; Leslie V. Parise; Eugene P. Orringer

  Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension

  Haematologica. 2008;93(1):20-26.
  51

• 14.

  2007

  Sheritha P. Lee; Kenneth I. Ataga; Mohamed Zayed; Jeanne M. Manganello; Eugene P. Orringer; David R. Phillips; Leslie V. Parise

  Phase I study of eptifibatide in patients with sickle cell anaemia

  British Journal of Haematology. 2007;139(4):612-620.
  15

• 15.

  2007

  Laine Elliott; Allison E. Ashley-Koch; Laura De Castro; Jude Jonassaint; Jennifer Price; Kenneth I. Ataga; Marc C. Levesque; J. Brice Weinberg; James R. Eckman; Eugene P. Orringer; et al.

  Genetic polymorphisms associated with priapism in sickle cell disease

  British Journal of Haematology. 2007;137(3):262-267.
  26

• 16.

  2006

  Lynne D. Neumayr; Christine Aguilar; Ann N. Earles; Harry E. Jergesen; Charles M. Haberkern; Bamidele F. Kammen; Paul A. Nancarrow; Eric Padua; Meredith Milet; Bernard N. Stulberg; et al.

  Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease: Results of a multicenter study at a mean of three years after treatment

  Journal of Bone and Joint Surgery - Series A. 2006;88(12):2573-2582.
  27

• 17.

  2006

  Kenneth I. Ataga; Eugene P. Orringer; Lori Styles; Elliott P. Vichinsky; Paul Swerdlow; George A. Davis; Philip A. DeSimone; Jonathan W. Stocker

  Dose-escalation study of ICA-17043 in patients with sickle cell disease

  Pharmacotherapy. 2006;26(11):1557-1564.
  16

• 18.

  2006

  William Crowley Jr.; John Courtney; Larry Jameson; Herbert Pardes; Jay Moskowitz; Eugene Orringer; Arthur Rubenstein; Alastair Wood; Richard Rettig; Dennis Ausiello; et al.

  The clinical research forum and association of american physicians disagree with criticism of the NIH Roadmap

  Journal of Clinical Investigation. 2006;116(8):2058-2059.
  6

• 19.

  2006

  Kenneth I. Ataga; Charity G. Moore; Susan Jones; Oludamilola Olajide; Dell Strayhorn; Alan Hinderliter; Eugene P. Orringer

  Pulmonary hypertension in patients with sickle cell disease

  British Journal of Haematology. 2006;134(1):109-115.
  116

• 20.

  2006

  Sheritha P. Lee; Kenneth I. Ataga; Eugene P. Orringer; David R. Phillips; Leslie V. Parise

  Biologically active CD40 ligand is elevated in sickle cell anemia: Potential role for platelet-mediated inflammation

  Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26(7):1626-1631.
  47

• 21.

  2006

  Patricia J. Byrns; Eugene P. Orringer

  Is the crisis in clinical research being effectively addressed?

  Journal of Investigative Medicine. 2006;54(1):10-12.
  0

• 22.

  2005

  Jing-He Yan; Kenneth Ataga; Sanjeev Kaul; Jeffery S. Olson; Dennis M. Grasela; Samantha Gothelf; Abdulah Kutlar; Eugene Orringer

  The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease

  Journal of Clinical Pharmacology. 2005;45(4):434-445.
  23

• 23.

  2004

  Kenneth I. Ataga; Namita Sood; Guy De Gent; Eileen Kelly; Ashley G. Henderson; Susan Jones; Dell Strayhorn; Alice Lail; Susan Lieff; Eugene P. Orringer

  Pulmonary hypertension in sickle cell disease

  American Journal of Medicine. 2004;117(9):665-669.
  85

• 24.

  2004

  Julia E. Brittain; Jaewon Han; Kenneth I. Ataga; Eugene P. Orringer; Leslie V. Parise

  Mechanism of CD47-induced α₄β₁ integrin activation and adhesion in sickle reticulocytes

  Journal of Biological Chemistry. 2004;279(41):42393-42402.
  31

• 25.

  2004

  Karen M. Gil; James W. Carson; Laura S. Porter; Cindy Scipio; Shawn M. Bediako; Eugene Orringer

  Daily Mood and Stress Predict Pain, Health Care Use, and Work Activity in African American Adults with Sickle-Cell Disease

  Health Psychology. 2004;23(3):267-274.
  47

• 26.

  2003

  Kenneth I. Ataga; Eugene P. Orringer

  Hypercoagulability in sickle cell disease: A curious paradox

  American Journal of Medicine. 2003;115(9):721-728.
  83

• 27.

  2003

  Patrick C. Hines; Qin Zen; Sharran N. Burney; Deborah A. Shea; Kenneth I. Ataga; Eugene P. Orringer; Marilyn J. Telen; Leslie V. Parise

  Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesion

  Blood. 2003;101(8):3281-3287.
  73

• 28.

  2003

  Martin H. Steinberg; Franca Barton; Oswaldo Castro; Charles H. Pegelow; Samir K. Ballas; Abdullah Kutlar; Eugene Orringer; Rita Bellevue; Nancy Olivieri; James Eckman; et al.

  Effect of Hydroxyurea on Mortality and Morbidity in Adult Sickle Cell Anemia: Risks and Benefits Up to 9 Years of Treatment

  Journal of the American Medical Association. 2003;289(13):1645-1651.
  340

• 29.

  2001

  E.P. Orringer; J.F. Casella; K.I. Ataga; M. Koshy; P. Adams-Graves; L. Luchtman-Jones; T. Wun; M. Watanabe; F. Shafer; A. Kutlar; et al.

  Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial

  Journal of the American Medical Association. 2001;286(17):2099-2106.
  78

• 30.

  2001

  Julia E. Brittain; Kathryn J. Mlinar; Christopher S. Anderson; Eugene P. Orringer; Leslie V. Parise

  Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin

  Blood. 2001;97(7):2159-2164.
  35

• 31.

  2001

  J.E. Brittain; K.J. Mlinar; C.S. Anderson; E.P. Orringer; L.V. Parise

  Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction

  Journal of Clinical Investigation. 2001;107(12):1555-1562.
  57

• 32.

  2000

  Elliott P. Vichinsky; Lynne D. Neumayr; Ann N. Earles; Roger Williams; Evelyne T. Lennette; Deborah Dean; Bruce Nickerson; Eugene Orringer; Virgil McKie; Rita Bellevue; et al.

  Causes and outcomes of the acute chest syndrome in sickle cell disease

  New England Journal of Medicine. 2000;342(25):1855-1865.
  356

• 33.

  2000

  K.I. Ataga; E.P. Orringer

  Bone marrow necrosis in sickle cell disease: A description of three cases and a review of the literature

  American Journal of the Medical Sciences. 2000;320(5):342-347.
  13

• 34.

  2000

  Karen M. Gil; James W. Carsona; Jan A. Sedway; Laura S. Porter; Jennifer J. Wilson Schaeffer; Eugene Orringer

  Follow-up of coping skills training in adults with sickle cell disease: Analysis of daily pain and coping practice diaries

  Health Psychology. 2000;19(1):85-90.
  24

• 35.

  2000

  Kenneth I. Ataga; Eugene P. Orringer

  Renal abnormalities in sickle cell disease

  American Journal of Hematology. 2000;63(4):205-211.
  97

• 36.

  2000

  Richard D. Moore; Samuel Charache; Michael L. Terrin; Franca B. Barton; Samir K. Ballas; E. Orringer; S. Jones; D. Strayhorn; W. Rosse; G. Phillips; et al.

  Cost-effectiveness of hydroxyurea in sickle cell anemia

  American Journal of Hematology. 2000;64(1):26-31.
  29

• 37.

  1999

  Richard E. Glover; Edward D. Ivy; Eugene P. Orringer; Hiroshi Maeda; Ronald P. Mason

  Detection of nitrosyl hemoglobin in venous blood in the treatment of sickle cell anemia with hydroxyurea

  Molecular Pharmacology. 1999;55(6):1006-1010.
  84

• 38.

  1999

  Jennifer J. Wilson Schaeffer; Karen M. Gil; Margaret Burchinal; Kathryn D. Kramer; Kermit B. Nash; Eugene Orringer; Dell Strayhorn

  Depression, disease severity, and sickle cell disease

  Journal of Behavioral Medicine. 1999;22(2):115-126.
  42

• 39.

  1999

  K.I. Ataga; M.L. Graham; H.N. Evans; P. Braeuning; E.P. Orringer

  Multiple myeloma in the breast

  American Journal of Hematology. 1999;61(3):203-204.
  6

• 40.

  1998

  Sheritha P. Lee; Michelle L. Cunningham; Patrick C. Hines; Christopher C. Joneckis; Eugene P. Orringer; Leslie V. Parise

  Sickle cell adhesion to laminin: Potential role for the α5 chain

  Blood. 1998;92(8):2951-2958.
  41

• 41.

  1997

  Pablo Gonzalez; Anthony C. Hackney; Susan Jones; Dell Strayhorn; Elaine Borland Hoffman; George Hughes; Edward E. Jacobs; Eugene P. Orringer

  A Phase I/II Study of Polymerized Bovine Hemoglobin in Adult Patients with Sickle Cell Disease not in Crisis at the Time of Study

  Journal of Investigative Medicine. 1997;45(5):258-264.
  31

• 42.

  1997

  K.M. Sullivan; M.C. Walters; M. Patience; W. Leisenring; G.R. Buchanan; O. Castro; S.C. Davies; R. Dickerhoff; J.R. Eckman; M.L. Graham; et al.

  Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders

  Bone Marrow Transplantation. 1997;19(SUPPL. 2):102-105.
  12

• 43.

  1997

  A.C. Hackney; W. Hezier; T.P. Gulledge; S. Jones; D. Strayhorn; M. Busby; E. Hoffman; E.P. Orringer

  Effects of hydroxyurea administration on the body weight, body composition and exercise performance of patients with sickle-cell anaemia

  Clinical Science. 1997;92(5):481-486.
  14

• 44.

  1997

  Charles M. Haberkern; Lynne D. Neumayr; Eugene P. Orringer; Ann N. Earles; Shanda M. Robertson; Dennis Black; Miguel R. Abboud; Mabel Koshy; Olajire Idowu; et al.

  Cholecystectomy in sickle cell anemia patients: Perioperative outcome of 364 cases from the national preoperative transfusion study

  Blood. 1997;89(5):1533-1542.
  75

• 45.

  1997

  S. Moll; E.P. Orringer

  Hemoglobin SC disease

  American Journal of Hematology. 1997;54(4):313.
  3

• 46.

  1996

  Stephan Moll; Eugene P. Orringer

  Case report: Splenomegaly and splenic sequestration in an adult with sickle cell anemia

  American Journal of the Medical Sciences. 1996;312(6):299-302.
  13

• 47.

  1996

  Christopher C. Joneckis; David D. Shock; Michelle L. Cunningham; Eugene P. Orringer; Leslie V. Parise

  Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions

  Blood. 1996;87(11):4862-4870.
  44

• 48.

  1996

  Spencer H. Shao; Eugene P. Orringer

  Case report: Splenic sequestration and multiorgan failure as the presenting manifestation of hemoglobin SC disease

  American Journal of the Medical Sciences. 1996;311(3):139-141.
  12

• 49.

  1996

  S. Charache; F.B. Barton; R.D. Moore; M.L. Terrin; M.H. Steinberg; G.J. Dover; S.K. Ballas; R.P. McMahon; O. Castro; E.P. Orringer; et al.

  Hydroxyurea and sickle cell anemia: Clinical utility of a myelosuppressive 'switching' agent

  Medicine. 1996;75(6):300-326.
  164

• 50.

  1996

  Karen M. Gil; Jennifer J. Wilson; Jennifer L. Edens; Deborah A. Webster; Mary A. Abrams; Eugene Orringer; Merida Grant; W. Crawford Clark; Malvin N. Janal

  Effects of cognitive coping skills training on coping strategies and experimental pain sensitivity in African American adults with sickle cell disease

  Health Psychology. 1996;15(1):3-10.
  51

• 51.

  1995

  George S. Hughes Jr.; Elizabeth P. Yancey; Rodney Albrecht; Paula K. Locker; Steven F. Francom; Eugene P. Orringer; Edward J. Antal; Edward E. Jacobs Jr.

  Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans

  Clinical Pharmacology and Therapeutics. 1995;58(4):434-443.
  53

• 52.

  1995

  S.H. Shao; E.P. Orringer

  Sickle cell intrahepatic cholestasis: Approach to a difficult problem

  American Journal of Gastroenterology. 1995;90(11):2048-2050.
  48

• 53.

  1995

  R.J. Spinner; E.P. Orringer; J.G. Kaplan; C.T. Nibley; R.L. Hall

  Isolated weakness of the extensor hallucis longus in a patient with hereditary spherocytosis

  Foot and Ankle International. 1995;16(2):100-102.
  3

• 54.

  1993

  C.C. Joneckis; R.L. Ackley; E.P. Orringer; E.A. Wayner; L.V. Parise

  Integrin α₄β₁ and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia

  Blood. 1993;82(12):3548-3555.
  134

• 55.

  1992

  E.P. Orringer; J.C. Parker

  Hydroxyurea and sickle cell disease

  Hematologic Pathology. 1992;6(4):171-178.
  4

• 56.

  1992

  R.J. Falk; J. Scheinman; G. Phillips; E. Orringer; A. Johnson; J.C. Jennette

  Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme

  New England Journal of Medicine. 1992;326(14):910-915.
  109

• 57.

  1992

  E.P. Orringer; D.S. Blythe; J.A. Whitney; S. Brockenbrough; D.J. Abraham

  Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes

  American Journal of Hematology. 1992;39(1):39-44.
  0

• 58.

  1992

  S. Charache; G.J. Dover; R.D. Moore; S. Eckert; S.K. Ballas; M. Koshy; P.F.A. Milner; E.P. Orringer; G. Phillips Jr.; O.S. Platt; et al.

  Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia

  Blood. 1992;79(10):2555-2565.
  195

• 59.

  1992

  M. Kawakami; Y. Endoh; E.P. Orringer; A.A. Meyer

  Improvements in rheologic properties of blood by fluid resuscitation after burn injury in rats

  Journal of Burn Care and Rehabilitation. 1992;13(3):316-322.
  3

• 60.

  1992

  Y. Endoh; M. Kawakami; E.P. Orringer; H.D. Peterson; A.A. Meyer

  Causes and time course of acute hemolysis after burn injury in the rat

  Journal of Burn Care and Rehabilitation. 1992;13(2 I):203-209.
  10

• 61.

  1992

  O.I. Aruoma; P. Swerdlow; E.P. Orringer; D.J. Abraham

  Dietary management of sickle cell anaemia with vanillin [1]

  Free Radical Research Communications. 1992;17(5):349-352.
  2

• 62.

  1991

  Eugene P. Orringer; David S.B. Blythe; Adrena E. Johnson; George Phillips Jr.; George J. Dover; John C. Parker

  Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia

  Blood. 1991;78(1):212-216.
  42

• 63.

  1991

  D.J. Abraham; A.S. Mehanna; F.C. Wireko; J. Whitney; R.P. Thomas; E.P. Orringer

  Vanillin, a potential agent for the treatment of sickle cell anemia

  Blood. 1991;77(6):1334-1341.
  29

• 64.

  1991

  B.P. Teehan; S. Krantz; W.A. Stone; S.E. Graber; P. Abraham; A. Dauer; J. Eschbach; J. Adamson; E. Friedman; C.D. Brown; et al.

  Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients

  American Journal of Kidney Diseases. 1991;18(1):50-59.
  110

• 65.

  1991

  E.P. Orringer; J.S. Brockenbrough; J.A. Whitney; P.S. Glosson; J.C. Parker

  Okadaic acid inhibits activation of K-Cl cotransport in red blood cells containing hemoglobins S and C

  American Journal of Physiology - Cell Physiology. 1991;261(4 30-4):C591-C593.
  20

• 66.

  1991

  E.P. Orringer; V.G. Fowler Jr.; C.M. Owens; A.E. Johnson; M.A. Mauro; F.G. Dalldorf; R.D. Croom

  Case report: Splenic infarction and acute splenic sequestration in adults with hemoglobin SC disease

  American Journal of the Medical Sciences. 1991;302(6):374-379.
  21

• 67.

  1991

  G. Phillips Jr.; B. Coffey; R. Tran-Son-Tay; T.R. Kinney; E.P. Orringer; R.M. Hochmuth

  Relationship of clinical severity to packed cell rheology in sickle cell anemia

  Blood. 1991;78(10):2735-2739.
  7

• 68.

  1990

  R. Antonucci; R. Walker; J. Herion; E. Orringer

  Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets

  American Journal of Hematology. 1990;34(1):44-48.
  19

• 69.

  1988

  S.N. Levine; L.R. Berkowitz; E.P. Orringer

  Inhibition of erythrocyte calcium transport by cetiedil

  Pharmacology. 1988;36(1):44-51.
  1

• 70.

  1987

  M. Callahan; S. Wall; F. Askin; D. Delaney; C. Koller; E.P. Orringer

  Granulocytic sarcoma presenting as pulmonary nodules and lymphadenopathy

  Cancer. 1987;60(8):1902-1904.
  12

• 71.

  1987

  L.R. Berkowitz; D. Walstad; E.P. Orringer

  Effect of N-ethylmaleimide on K transport in density-separated human red blood cells

  American Journal of Physiology - Cell Physiology. 1987;253(1):22/1.
  2

• 72.

  1987

  E. Murphy; L.R. Berkowitz; E. Orringer; L. Levy; S.A. Gabel; R.E. London

  Cytosolic free calcium levels in sickle red blood cells

  Blood. 1987;69(5):1469-1474.
  18

• 73.

  1987

  J.D. Reed; R. Redding-Lallinger; E.P. Orringer

  Nutrition and sickle cell disease

  American Journal of Hematology. 1987;24(4):441-455.
  26

• 74.

  1987

  L.R. Berkowitz; E.P. Orringer

  Cell volume regulation in hemoglobin CC and AA erythrocytes

  American Journal of Physiology - Cell Physiology. 1987;252(3):21/3.
  2

• 75.

  1986

  P. Larson; M. Mayer; L.R. Berkowitz; E.P. Orringer

  Hemoglobin SC disease causing ischemic necrosis.

  North Carolina medical journal. 1986;47(3):113-114.
  2

• 76.

  1986

  E. Murphy; L. Levy; L.R. Berkowitz; E.P. Orringer; S.A. Gabel; R.E. London

  Nuclear magnetic resonance measurement of cytosolic free calcium levels in human red blood cells

  American Journal of Physiology - Cell Physiology. 1986;251(4):20/4.
  5

• 77.

  1986

  L.J. Benjamin; L.R. Berkowitz; E. Orringer; V.N. Mankad; A.S. Prasad; L.M. Lewkow; R.K. Chillar; C.M. Peterson

  A collaborative, double-blind randomized study of cetiedil citrate in sickle cell crisis

  Blood. 1986;67(5):1442-1447.
  23

• 78.

  1986

  R. Rutledge; R.D. Croom III.; J.W. Davis Jr.; L.R. Berkowitz; E.P. Orringer

  Cholelithiasis in sickle cell anemia: Surgical considerations

  Southern Medical Journal. 1986;79(1):28-30.
  14

• 79.

  1986

  E.P. Orringer; J.R. Powell; R.E. Cross; J.F. Rogers; O. Wojcieszyn; J.C. Phillips; J. Reed; L.R. Berkowitz

  A single-dose pharmacokinetic study of the antisickling agent cetiedil

  Clinical Pharmacology and Therapeutics. 1986;39(3):276-281.
  2

• 80.

  1986

  R.D. Croom III; C.W. McMillan; E.P. Orringer; G.F. Sheldon

  Hereditary spherocytosis: Recent experience and current concepts of pathophysiology

  Annals of Surgery. 1986;203(1):34-39.
  17

• 81.

  1985

  L.R. Berkowitz; E.P. Orringer

  Passive sodium and potassium movements in sickle erythrocytes.

  The American journal of physiology. 1985;249(3 Pt 1):C208-214.
  12

• 82.

  1985

  L.R. Berkowitz; E.P. Orringer

  Passive sodium and potassium movements in sickle erythrocytes

  American Journal of Physiology - Cell Physiology. 1985;18(2):C208-C214.
  3

• 83.

  1984

  L.R. Berkowitz; E.P. Orringer

  An analysis of the mechanism by which cetiedil inhibits the Gardos phenomenon

  American Journal of Hematology. 1984;17(3):217-223.
  3

• 84.

  1984

  S.N. Levine; L.R. Berkowitz; E.P. Orringer

  Cetiedil inhibition of calmodulin-stimulated enzyme activity

  Biochemical Pharmacology. 1984;33(4):581-584.
  1

• 85.

  1984

  E.P. Orringer

  A further characterization of the selective K movements observed in human red blood cells following acetylphenylhydrazine exposure

  American Journal of Hematology. 1984;16(4):355-366.
  3

• 86.

  1984

  C.A. Koller; E.P. Orringer; L.R. Berkowitz; A.T. Mulhern

  Role of glycolysis in deoxyadenosine induced ATP depletion and dATP accumulation in red cells.

  Progress in clinical and biological research. 1984;165:227-239.
  1

• 87.

  1984

  L.R. Berkowitz; E.P. Orringer

  Abnormal ouabain-insensitive potassium (K) movements in sickle erythrocytes (SSRBC)

  Federation Proceedings. 1984;43(4):no. 4638.
  0

• 88.

  1983

  W.T. Thorwarth Jr.; P.F. Jaques; E.P. Orringer

  Polyarteritis nodosa in hairy cell leukemia.

  Journal of the Canadian Association of Radiologists. 1983;34(2):151-152.
  1

• 89.

  1983

  J.E. Peacock; J. Folds; E. Orringer; B. Luft; M.S. Cohen

  Toxoplasma gondii and the compromised host. Antibody response in the absence of clinical manifestations of disease

  Archives of Internal Medicine. 1983;143(6):1235-1237.
  0

• 90.

  1983

  E.P. Orringer

  The role of membrane abnormalities of red cells in the pathophysiology of sickle cell disease

  Clinical Respiratory Physiology. 1983;19(4):377-378.
  0

• 91.

  1982

  P. Agre; E.P. Orringer; V. Bennett

  Deficient red-cell spectrin in severe, recessively inherited spherocytosis

  New England Journal of Medicine. 1982;306(19):1155-1161.
  44

• 92.

  1982

  M.L. Gulley; D.W. Ross; C. Feo; E.P. Orringer

  The effect of cell hydration on the deformability of normal and sickle erythrocytes

  American Journal of Hematology. 1982;13(4):283-291.
  5

• 93.

  1982

  L.R. Berkowitz; E.P. Orringer

  Effects of cetiedil on monovalent cation permeability in the erythrocyte: An explanation for the efficacy of cetiedil in the treatment of sickle cell anemia

  Blood Cells. 1982;8(2):283-288.
  10

• 94.

  1982

  F.S. Collins; E.P. Orringer

  Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies

  American Journal of Medicine. 1982;73(6):814-821.
  63

• 95.

  1981

  E.C. Wilson; A.A. Geddie; E.P. Orringer; S.A. Stass

  Pappenheimer bodies and spuriously elevated platelet counts.

  Journal of the American Medical Association. 1981;246(9):938.
  0

• 96.

  1981

  L.R. Berkowitz; E.P. Orringer

  Effect of cetiecil, an in vitro antisickling agent, on erythrocyte membrane cation permeability

  Journal of Clinical Investigation. 1981;68(5):1215-1220.
  21

• 97.

  1981

  P. Agre; E.P. Orringer; D.H.K. Chui; V. Bennett

  A molecular defect in two families with hemolytic poikilocytic anemia. Reduction of high affinity membrane binding sites for ankyrin

  Journal of Clinical Investigation. 1981;68(6):1566-1576.
  7

• 98.

  1980

  E.P. Orringer; M.E.S. Roer; J.C. Parker

  Cell density profile as a measure of erythrocyte hydration: Therapeutic alteration of salt and water content in normal and SS red blood cells

  Blood Cells. 1980;6(3):345-353.
  0

• 99.

  1980

  E.P. Orringer; M.A. Varia

  A role for radiation in the treatment of hairy cell leukemia complicated by massive lymphadenopathy. A case report

  Cancer. 1980;45(8):2047-2050.
  0

• 100.

  1980

  B.D. Morton; E.P. Orringer; L.A. LaHart; S.A. Stass

  An additional cause for a spurious platelet count

  American Journal of Clinical Pathology. 1980;74(3):310-311.
  7

• 101.

  1980

  L.R. Berkowitz; D.W. Ross; E.P. Orringer

  Hairy cell leukemia with acquired dyserythropoiesis

  Archives of Internal Medicine. 1980;140(4):554-555.
  4

• 102.

  1979

  E.P. Orringer; M.E.S. Roer

  An ascorbate-mediated transmembrane-reducing system of the human erythrocyte

  Journal of Clinical Investigation. 1979;63(1):53-58.
  64

• 103.

  1979

  C.A. Koller; E.P. Orringer; J.C. Parker

  Quinine protects pyruvate-kinase deficient red cells from dehydration

  American Journal of Hematology. 1979;7(3):193-199.
  0

• 104.

  1979

  J.R. Harper Jr.; E.P. Orringer; J.C. Parker

  Adriamycin inhibits Ca permeability and Ca-dependent K movements in red blood cells

  Research Communications in Chemical Pathology and Pharmacology. 1979;26(2):277-284.
  2

• 105.

  1979

  J.C. Goldsmith; M.E.S. Roer; E.P. Orringer

  A new treatment strategy for hemophilia B: Incorporation of Factor IX into red cell ghosts

  American Journal of Hematology. 1979;7(2):119-125.
  2

• 106.

  1978

  E.P. Orringer; A. Felice; A. Reese

  Hb Nottingham (α₂β₂ (FG5) 98 VAL[GLY) in a caucasian male: Clinical and biosynthetic studies

  Hemoglobin. 1978;2(4):315-332.
  3

• 107.

  1978

  J.R. Harper Jr.; D.W. Ross; E.P. Orringer; J.C. Parker

  Actions of doxorubicin (adriamycin) on the red blood cell membrane

  Clinical Research. 1978;26(6):795A.
  0

• 108.

  1978

  E.P. Orringer; M.E.S. Roer

  An ascorbic acid mediated erythrocyte trans-membrane reducing system

  Clinical Research. 1978;26(3):354A.
  0

• 109.

  1977

  P.D. Utsinger; W.J. Yount; C.R. Fuller; M.J. Logue; E.P. Orringer

  Hairy cell leukemia: B lymphocyte and phagocytic properties

  Blood. 1977;49(1):19-27.
  9

• 110.

  1977

  W.D. Heizer; E.P. Orringer

  Parenteral nutrition at home for 5 years via arteriovenous fistulae. Supplemental intravenous feedings for a patient with severe short bowel syndrome

  Gastroenterology. 1977;72(3):527-532.
  9

• 111.

  1977

  E.P. Orringer; J.C. Parker

  Selective increase of potassium permeability in red blood cells exposed to acetylphenylhydrazine

  Blood. 1977;50(6):1013-1021.
  1

• 112.

  1976

  E.P. Orringer; J.B. Wilson; T.H.J. Huisman

  Hemoglobin Chapel Hill or α₂ ^Asp→Glyβ₂

  FEBS Letters. 1976;65(3):297-300.
  0

• 113.

  1976

  H.R. Lesesne; W. Holt; E. Orringer

  Letter: Is hepatic abscess a contraindication to percutaneous liver biopsy?

  Gastroenterology. 1976;70(2):297-298.
  0

• 114.

  1976

  E.P. Orringer; W.D. Mattern

  Formaldehyde induced hemolysis during chronic hemodialysis

  New England Journal of Medicine. 1976;294(26):1416-1420.
  15

• 115.

  1976

  E.P. Orringer; M.J. Koury; P.M. Blatt; H.R. Roberts

  Hemolysis caused by factor VIII concentrates

  Archives of Internal Medicine. 1976;136(9):1018-1020.
  7

• 116.

  1973

  E.P. Orringer; J.C. Parker

  Ion and water movements in red blood cells.

  Progress in hematology. 1973;8:1-23.
  0

• 117.

  1971

  E.P. Orringer; F.R. Weiss; H.G. Preuss

  Azotaemic inhibition of organic anion transport in the kidney of the rat: mechanisms and characteristics.

  Clinical science. 1971;40(2):159-169.
  1

• 118.

  1970

  Eugene Orringer; Marvin Lewis; Jay Silverberg; Loren Rosenbach

  Splenectomy in chronic thrombocytopenic purpura

  Journal of Chronic Diseases. 1970;23(2):117-122.
  2